Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ACARBOSE
- A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers
- Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients
- Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes
- The Efficacy and Tolerability of Acarbose in Healthy Individuals
- A Pilot Study of the Immunomodulatory Agent Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)
- Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo
- Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and Acarbose
- A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
- A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary)
- Bioequivalence Study for Acarbose/Metformin FDC
- Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.
- Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive
- Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
- Research of Intensive Metabolic Intervention Before Pregnancy in PCOS
- Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus.
- Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy
- Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients
- A Phase IV Study in Drug-Naive Patients With T2DM in China
- Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines
- Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell
- Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients
- Study of Acarbose in Longevity
- Acarbose Anti-aging Effects in Geriatric Subjects (Substudy B & C)
- Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
- Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
- Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes
- Human Oral Detection of Glucose Olygomers
- Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens
- Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients
- Incretin-based Drugs and Acute Pancreatitis
- Incretin-based Drugs and Pancreatic Cancer
- Saxagliptin's Effects on Microalbuminuria Improvement in Type 2 Diabetic Patients
- Incretin-based Drugs and the Risk of Heart Failure
- Research of Intensive Lifestyle Intervention for PCOS Patients With IGT
- the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix Insulin
- BTI320 (SUGARDOWN®) on Post-Prandial Hyperglycaemia in Subjects With Pre-Diabetes
- Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant Patients
- Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes
- 24-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With T2D Inadequately
- Relative Bioavailability of BI 44847 in Different Ethnic Groups and Evaluation of Effect of Diet and Acarbose Coadministration on Bioavailability Following Oral Administration of 200 mg BI 44847 in Healthy Male Volunteers
- Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension
- Efficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes Mellitus
- A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
- Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes
- Acarbose, Postprandial Hypotension and Type 2 Diabetes
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Study to Assess the Dietary Carbohydrate Content of Indian Diabetics With Special Therapeutic View on Effectiveness of Acarbose and Metformin Monotherapy
- SOMATULINE Autogel 90 mg IN DUMPING SYNDROME
- GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice
- Acarbose and Older Adults With Postprandial Hypotension
- Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes.
- Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes
- Bioequivalence Study for Acarbose / Metformin FDC
- A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)
- Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes
- A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus
- Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients
- Early Diabetes Intervention Program
- Influence of Different Approaches to Dietary Advising on the Effects of Acarbose Treatment in Obese Diabetic Patients Under Real-life Setting
- Efficacy and Safety of Oral Acarbose Treatment in Patients With Type 2 Diabetes Mellitus
- Metformin Versus Acarbose Treatment in Infertile Overweight Women With Polycystic Ovary Syndrome (PCOS)
- A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus
- Exercise and Acarbose in Type 2 Diabetes
- A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients
- Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)
- Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)
- Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy
- Prevention of Postprandial Hyperglycemia by Acarbose May be a Promising Therapeutic Strategy for Reducing the Increased Risk for Cardiovascular Disease
- Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion
- The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus Ribavirin
- Role of Insulin Action and Free Fatty Acids in Hyperandrogenism of Women With Polycystic Ovary Syndrome
- Prevent/Delay Development of Type 2 Diabetes in Subjects With Impaired Glucose Homeostasis Treated With Acarbose in Primary Care
- Vildagliptin and Endothelium-dependent Vasodilatation
- Glucose Reduction by Early Acarbose Treatment in Basal Insulin
- Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors
- Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial)
- Study of Post-meal Blood Sugar Peaks in Association With Vascular Disease in Childhood Obesity
- Acarbose Cardiovascular Evaluation Trial
- Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia
- A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)
- Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM Trial
- AI(I)DA Acarbose and the Subclinical Inflammation
- Effects of Acarbose on Endothelial Function After a Mixed Meal in Newly Diagnosed Type 2 Diabetes
- Japan Early Diabetes Intervention Study
- The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients
- Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 Diabetes
- Effects of Acarbose Versus Glibenclamide on MAGE and Oxidative Stress in Patients With Type 2 DM
- Treatment of Orthostatic Hypotension in Autonomic Failure
- Acarbose and Secondary Prevention After Coronary Stenting
- Preferred Treatment of Type 1.5 Diabetes
- Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 Diabetes
- Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)
- Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Clinical trials list
click for details